to set up a standing committee to watch over these ethical problems is as welcome as are its two codes. In these and other statements it has shown itself to be solicitous for the individual patient's welfare and guided by the strictest ethical criteria, while published reports of its research workers have always set an example of scrupulous conduct. This too is worth bearing in mind when researchers look for guidance in the codes. The M.R.C. practises to the high standards it preaches.
I Committee on Privacy, Report, Cmnd. 5012. London, H.M.S.O., 1972. 2 British Medical Yournal, 1972 , 3, 189. Medical Research Council, British Medical Yournal, 1964 .
Glucagon and Growth Hormone
There are several stimuli to the secretion of growth hormone. They include physical activity, stress, hypoglycaemia, a rise in blood amino-acids, administration of amphetamine or propranolol, and simply falling asleep at night or snoozing during the day. While the mechanisms by which these stimuli work are not fully understood, they may be used when investigating a patient suspected of having insufficient growth hormone. A diagnosis of any pituitary hormone deficiency should be accepted only if the blood levels fail to rise during a potent stimulus to the hormone's release. This is particularly important when considering growth hormone, since it is in short supply and treatment with it is effective only in growthretarded children who lack it. Other forms of dwarfism do not respond.' The detection of impaired secretion of growth hormone in adults may also be of diagnostic importance, since it is affected much earlier than corticotrophin or thyroid-stimulating hormone in most cases of progressive pituitary or hypothalamic disease, usually shortly after impairment of gonadotrophin secretion. A fall in raised blood sugar level will cause secretion of growth hormone even though the level it sinks to is not low enough itself to produce hypoglycaemic symptoms. It has therefore been suggested that the response of the growth hormone to the decline in blood sugar levels after the peak of an oral glucose tolerance test can be used as a test.6 J. Roth and his colleagues in 19637 first followed the rise in growth hormone which occurs after the administration of glucagon, and since then from time to time reports of the response of this hormone to glucagon have appeared. However, its value in pituitary investigation has been controversial. Some have stated that secretion of growth hormone responds directly to administration of glucagon independently of any blood sugar changes;8 others have said that the responses are inconsistent and are related only to the stress of the nausea often induced by glucagon.9 Enthusiastic supporters of the glucagon test maintain that the effect is specific, consistent, and direct, being independent of fluctuations in blood sugar.10 Describing the procedure, M. L. Mitchell and colleagues'1 advised administration of 1 mg of glucagon subcutaneously, with blood sampling over the subsequent three hours. The blood sugar initially rises to reach a peak at 30-45 minutes from the start and then falls to reach a nadir at around 120 minutes, usually a little below the initial fasting levels. At or after this time serum levels of growth hormone begin to rise, reaching a a peak at 180 minutes. Those authors considered that a rise of more than 6 ng/ml serum was normal.
J. P. Cain and colleagues'2 clarified some confused earlier reports when they compared the effects of giving glucagon by different routes. When glucagon was given as a bolus intravenously, the growth hormone response was virtually immediate and rose with the blood sugar, but this occurred in only about 50% of normal persons. When it was given subcutaneously the response was more consistent but occurred only after the blood sugar had fallen from its peak; it m;ght be missed if blood samples were not obtained after 90 minutes.
This group of workers has now reported the results of glucagon tests in normal persons and patients with diseases of the pituitary or hypothalamus and has compared these results with those of other tests of growth hormone reserve.13 They found that 1 of 20 normal persons failed to show a growth hormone response to 1 mg of subcutaneous glucagon, whereas 3 of 20 failed to respond to intravenous arginine even though the men were pretreated with stilboestrol. These results compared with no false negative results in the 10 persons tested with insulin-induced hypoglycaemia even though these workers used a smaller dose of intravenous insulin than would usually be recommended.
While it seems to be agreed that the glucagon test is rather better and easier to perform than the arginine infusion test, it is hard to agree with the authors that they have shown it to be superior to the insulin tolerance test except when the latter cannot be performed on general medical grounds. Of the patients suspected of hypopituitarism some showed abnormal responses to arginine but normal responses to glucagon, while others who responded to arginine failed to respond to glucagon. Unfortunately none of the patients were tested with insulin-induced hypoglycaemia.
The mechanisms involved in the delayed release of growth hormone after subcutaneous glucagon remain un-clear. Certainly it occurs as the blood glucose returns towards or past the basal levels, but most workers have been unable to relate the extent of the rise in the hormone to the degree of blood sugar fall. Many maintain that release of the hormone is therefore due to a direct action of glucagon on the hypothalamus or pituitary, but in at least one patient prevention of the fall in blood sugar with a glucose infusion is reported to have blocked the rise in growth hormone.10 A recent study14 supports the view that release of growth hormone is indeed related to the fall in blood sugar, for when the blood sugar changes after glucagon were greatly reduced by fasting for 48 hours there was no growth hormone response to glucagon, though the patients still secreted the hormone after arginine infusion. It seems unlikely that the growth hormone response is merely related to stress, since not all patients become nauseated after glucagon.
Most studies suggest that plasma corticosteroids do not rise consistently or specifically after glucagon whether given intravenously or subcutaneously, though others contradict this.9 15 The general conclusion may be drawn that insulininduced hypoglycaemia remains the procedure of choice when investigating the anterior pituitary's capacity to secrete growth hormone, for as a test it is reliable, short in duration, and gives information about corticotrophin reserve as well as growth hormone. When the insulin test cannot be performed, glucagon stimulation provides a good second-line test, probably superior to administration of arginine. But it takes longer to perform than the insulin tolerance test and is rather less reliable.
For several decades controversy has surrounded the desirability or need for gastric decompression in the immediate postoperative period after abdominal operations in general and more particularly after operations on the stomach itself. In the 1930s many surgeons adopted suction via an indwelling nasogastric tube, which had been popularized by 0. H. Wangensteen and J. R. Paine' in the conservative management of intestinal obstruction and paralytic ileus, as part of the routine postoperative care of patients after elective gastric and other abdominal operations. But instead of using a motor or a suitable arrangement of bottles to provide suction most surgeons preferred to rely on intermittent aspiration with a syringe, which has the advantage of greater simplicity and of providing a regular sampling of the gastric contents.
The main objection to suction by nasogastric tube is the discomfort of the tube to the patient, who usually regards this as one of the more unpleasant aspects of his recovery. Such tubes have also been said to predispose to postoperative respiratory complications by interfering with coughing. And if maintained for long in position they have been thought to lead to peptic oesophagitis and oesophageal stricture by encouraging regurgitation of gastric contents. These considerations have led many surgeons to resort to a temporary gastrostomy instead of nasogastric suction,2-5 for it spares the patient the inconvenience of an indwelling tube in the nose and pharynx; but according to some surgeons it increases the risks of sepsis in the abdominal wound6 and may occasionally result in peritonitis or gastric fistulation.7
More recently some surgeons have come to doubt the necessity for any form of routine postoperative gastric decompression. They have been prepared to leave their patients without a nasogastric or gastrostomy tube in the first instance, accepting that in some of them vomiting will require the subsequent passage of a Ryle's tube for gastric aspiration.89 It has been argued, however, that before the patient reaches the stage of vomiting considerable gastric distention will have occurred, which might expose any gastrointestinal suture line to an increased risk of disruption.4 10 The relative merits of these regimens are still hotly disputed despite a number of comparative investigations.7 11 But these were uncontrolled retrospective studies. Now D. F. Miller and his colleagues at the Victoria Infirmary, Glasgow,7 have pulblished an account of a controlled prospective trial of nasogastric tube aspiration, gastrostomy, and gastric decompression in the aftercare of 132 patients treated by vagotomy and drainage. It has shown some interesting results.
Clinical signs of a chest infection were present in 43% of the patients. They were noted in 24 of the 47 who had had a nasogastric tube, in 21 of the 43 who had had a gastrostomy, and in 12 of the 42 who had been treated without gastric decompression. The difference in the rate of chest infection between the group with a nasogastric tube and those with no form of gastric tube is statistically significant. Incidentally this study underlines the role of smoking in predisposing to postoperative chest infection. Of the 57 patients who developed chest infection 51 (89-4%) were smokers, and only 6 (10-60%) were non-smokers.
Wound infection occurred in 6 of the group with nasogastric tube, in 9 of the gastrostomy group, and in 2 of those without a tube. The difference between the rates of infection in the gastrostomy group and the tubeless group is statistically significant.
It is interesting to note the patients' assessment of the discomfort of nasogastric tubes and gastrostomies. Of the 47 patients who had nasogastric suction 14 found the symptoms referable to it "bearable" and 33 considered them "unpleasant" or "distressing"; 19 were of the opinion that a gastrostomy might have been preferalble. Of the 43 patients with a gastrostomy 36 described the symptoms relating to it as "bearable," and 40 would choose a gastrostomy again, only
